iRhythm Technologies (IRTC) Competitors $100.34 -5.58 (-5.27%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$100.42 +0.08 (+0.07%) As of 04/4/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRTC vs. SOLV, SNN, PEN, STVN, GKOS, BLCO, INSP, NARI, SLNO, and PRCTShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), Soleno Therapeutics (SLNO), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Solventum Smith & Nephew Penumbra Stevanato Group Glaukos Bausch + Lomb Inspire Medical Systems Inari Medical Soleno Therapeutics PROCEPT BioRobotics Solventum (NYSE:SOLV) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, community ranking, analyst recommendations and earnings. Does the media favor SOLV or IRTC? In the previous week, Solventum had 4 more articles in the media than iRhythm Technologies. MarketBeat recorded 13 mentions for Solventum and 9 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.15 beat Solventum's score of 1.08 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 10 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in SOLV or IRTC? iRhythm Technologies received 408 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 66.07% of users gave iRhythm Technologies an outperform vote while only 4.17% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes14.17%Underperform Votes2395.83% iRhythm TechnologiesOutperform Votes40966.07% Underperform Votes21033.93% Which has better earnings & valuation, SOLV or IRTC? Solventum has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.25B1.39$475.72M$2.7524.08iRhythm Technologies$591.84M5.33-$123.41M-$3.64-27.57 Do analysts prefer SOLV or IRTC? Solventum presently has a consensus target price of $79.86, suggesting a potential upside of 20.60%. iRhythm Technologies has a consensus target price of $119.73, suggesting a potential upside of 19.32%. Given Solventum's higher probable upside, research analysts plainly believe Solventum is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00iRhythm Technologies 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.82 Is SOLV or IRTC more profitable? Solventum has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Solventum's return on equity of 0.00% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A iRhythm Technologies -19.14%-118.83%-11.34% SummarySolventum beats iRhythm Technologies on 9 of the 15 factors compared between the two stocks. Remove Ads Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.15B$3.99B$5.24B$7.07BDividend YieldN/A37.84%4.87%4.05%P/E Ratio-27.5727.4321.2217.46Price / Sales5.3346.24356.5585.24Price / CashN/A51.0838.1634.64Price / Book14.655.696.233.79Net Income-$123.41M$67.64M$3.20B$247.10M7 Day Performance-4.44%-8.36%-8.26%-6.72%1 Month Performance-6.82%-9.02%-4.66%-11.41%1 Year Performance-10.22%5.02%2.63%-7.74% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies1.8526 of 5 stars$100.34-5.3%$119.73+19.3%-6.5%$3.15B$591.84M-27.571,790News CoveragePositive NewsSOLVSolventum1.3712 of 5 stars$76.02+1.7%$79.86+5.0%-1.2%$13.15B$8.25B27.6422,000Positive NewsGap DownSNNSmith & Nephew2.835 of 5 stars$28.39+1.2%$27.00-4.9%+8.2%$12.41B$5.81B13.1420,100Positive NewsPENPenumbra4.5978 of 5 stars$267.84+0.1%$294.47+9.9%+21.8%$10.32B$1.19B787.773,900Insider TradeAnalyst RevisionNews CoverageGap DownSTVNStevanato Group1.5127 of 5 stars€20.37+0.4%N/A-37.3%$6.17B$1.10B43.344,650Positive NewsGap DownGKOSGlaukos3.8751 of 5 stars$98.49-3.4%$163.25+65.8%-11.2%$5.57B$383.48M-34.32780News CoveragePositive NewsGap DownBLCOBausch + Lomb3.7222 of 5 stars$14.50+2.6%$19.18+32.3%-25.5%$5.11B$4.79B-15.9312,500Analyst ForecastNews CoverageHigh Trading VolumeINSPInspire Medical Systems4.83 of 5 stars$159.60+1.5%$226.70+42.0%-34.5%$4.75B$802.80M92.261,246News CoveragePositive NewsNARIInari Medical0.9545 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800SLNOSoleno Therapeutics4.4957 of 5 stars$71.45-0.8%$98.86+38.4%+63.4%$3.28BN/A-21.5230Insider TradeAnalyst RevisionHigh Trading VolumePRCTPROCEPT BioRobotics2.5729 of 5 stars$58.26-3.0%$94.29+61.8%+12.0%$3.19B$224.50M-29.88430News CoveragePositive News Remove Ads Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Bausch + Lomb Alternatives Inspire Medical Systems Alternatives Inari Medical Alternatives Soleno Therapeutics Alternatives PROCEPT BioRobotics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRTC) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IRTC Stock Free IRTC Stock Alerts